GG 367 (Benazepril hydrochloride and hydrochlorothiazide 20 mg / 25 mg)
Pill imprint GG 367 has been identified as Benazepril hydrochloride and hydrochlorothiazide 20 mg / 25 mg.
Benazepril is used in the treatment of high blood pressure; diabetic kidney disease; left ventricular dysfunction; heart failure and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy. Benazepril 20 mg / 25 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for GG 367 (Benazepril hydrochloride and hydrochlorothiazide 20 mg / 25 mg)
- 20 mg / 25 mg
- Elliptical / Oval
- Prescription only
- Drug Class:
- Angiotensin converting enzyme inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Sandoz Pharmaceuticals Inc.
- National Drug Code (NDC):
|NDC Code||Manufacturer / Repackager|
|33358-0050||Core Pharmaceuticals Inc (repackager)|
Note: Inactive ingredients may vary.
More about benazepril
- Other brands: Lotensin